Studies have shown that HBXIP mediates the upregulation of methyltransferase-like 3 (METTL3) and promotes glycolysis by facilitating the methylation modification of HIF-1α, thereby enhancing the malignant biological behavior of HCC (84). This evidence concerns the gene HIF1A and hepatocellular carcinoma.